共 14 条
Prognostic role of p-mTOR expression in cancer tissues and metastatic lymph nodes in pT2b gastric cancer
被引:61
作者:

论文数: 引用数:
h-index:
机构:

Kim, Kyoung Mee
论文数: 0 引用数: 0
h-index: 0
机构:
Sungkyunkwan Univ, Dept Pathol, Samsung Med Ctr, Sch Med, Seoul 135710, South Korea Sungkyunkwan Univ, Dept Surg, Samsung Med Ctr, Sch Med, Seoul 135710, South Korea

Choi, Min Gew
论文数: 0 引用数: 0
h-index: 0
机构:
Sungkyunkwan Univ, Dept Surg, Samsung Med Ctr, Sch Med, Seoul 135710, South Korea Sungkyunkwan Univ, Dept Surg, Samsung Med Ctr, Sch Med, Seoul 135710, South Korea

Noh, Jae Hyung
论文数: 0 引用数: 0
h-index: 0
机构:
Sungkyunkwan Univ, Dept Surg, Samsung Med Ctr, Sch Med, Seoul 135710, South Korea Sungkyunkwan Univ, Dept Surg, Samsung Med Ctr, Sch Med, Seoul 135710, South Korea

Sohn, Tae Sung
论文数: 0 引用数: 0
h-index: 0
机构:
Sungkyunkwan Univ, Dept Surg, Samsung Med Ctr, Sch Med, Seoul 135710, South Korea Sungkyunkwan Univ, Dept Surg, Samsung Med Ctr, Sch Med, Seoul 135710, South Korea

论文数: 引用数:
h-index:
机构:

Kim, Sung
论文数: 0 引用数: 0
h-index: 0
机构:
Sungkyunkwan Univ, Dept Surg, Samsung Med Ctr, Sch Med, Seoul 135710, South Korea Sungkyunkwan Univ, Dept Surg, Samsung Med Ctr, Sch Med, Seoul 135710, South Korea
机构:
[1] Sungkyunkwan Univ, Dept Surg, Samsung Med Ctr, Sch Med, Seoul 135710, South Korea
[2] Yonsei Univ, Coll Med, Dept Surg, Seoul, South Korea
[3] Sungkyunkwan Univ, Dept Pathol, Samsung Med Ctr, Sch Med, Seoul 135710, South Korea
关键词:
gastric cancer;
p-mTOR;
prognostic marker;
surgery;
lymph node metastasis;
MAMMALIAN TARGET;
PHASE-II;
TEMSIROLIMUS CCI-779;
GROWTH-FACTOR;
RAPAMYCIN;
INHIBITOR;
PATHWAY;
ANTIANGIOGENESIS;
THERAPY;
TUMORS;
D O I:
10.1002/ijc.24872
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
Despite the great interest in mammalian target of rapamycin (mTOR) as a potential anticancer therapy target, the prognostic role of mTOR in gastric cancer has not been elucidated. In this study, we investigated mTOR expression in gastric cancer tissues and in metastatic lymph nodes and examined its association with clinical outcome. A total of 290 patients with pT2b gastric cancer were enrolled in this study. Patients were divided into 3 groups according to metastatic lymph node status: Group 1 contained 96 patients without lymph node metastasis, Group 2 contained 102 patients with a few (1-2) metastatic lymph nodes and Group 3 contained 92 patients with extensive (>16) lymph node metastasis. Phosphorylated mTOR expression was determined immunohistochemically using tissue microarrays. p-mTOR expression was observed in 36.5% of the gastric cancer tissues in Group 1, 39.2% in Group 2 and 60.9% in Group 3. A significant correlation was found between p-mTOR expression in gastric cancer tissues and in metastatic lymph nodes. The Borrmann type in Group 1, perineural invasion and p-mTOR expression in metastatic lymph nodes in Group 2 and p-mTOR expression in metastatic lymph nodes in Group 3 were found to be independent prognostic factors of disease-free survival. The 5-year disease free survival rate of Group 2 patients was 84.4% in negative p-mTOR and 66.1% in positive p-mTOR expression in metastatic lymph nodes (p = 0.015). The 5-year disease free survival rate of Group 3 patients was 37.3% in negative p-mTOR and 14.9% in positive p-mTOR expression in metastatic lymph nodes (p = 0.037). There was a linear correlation between the rate of tumor recurrence and mTOR expression scores in metastatic lymph nodes. In pT2b gastric cancer, p-mTOR expression in gastric cancer is associated with the extent of lymph node metastasis, and p-mTOR expression in metastatic lymph nodes is correlated with poor disease-free survival. mTOR may harbor significant potential for a prognostic biomarker and therapeutic target for gastric cancer treatment.
引用
收藏
页码:2904 / 2913
页数:10
相关论文
共 14 条
[1]
Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma
[J].
Atkins, MB
;
Hidalgo, M
;
Stadler, WM
;
Logan, TF
;
Dutcher, JP
;
Hudes, GR
;
Park, Y
;
Lion, SH
;
Marshall, B
;
Boni, JP
;
Dukart, G
;
Sherman, ML
.
JOURNAL OF CLINICAL ONCOLOGY,
2004, 22 (05)
:909-918

Atkins, MB
论文数: 0 引用数: 0
h-index: 0
机构: Beth Israel Deaconess Med Ctr, Dept Med, Div Hematol Oncol, Boston, MA 02215 USA

Hidalgo, M
论文数: 0 引用数: 0
h-index: 0
机构: Beth Israel Deaconess Med Ctr, Dept Med, Div Hematol Oncol, Boston, MA 02215 USA

Stadler, WM
论文数: 0 引用数: 0
h-index: 0
机构: Beth Israel Deaconess Med Ctr, Dept Med, Div Hematol Oncol, Boston, MA 02215 USA

Logan, TF
论文数: 0 引用数: 0
h-index: 0
机构: Beth Israel Deaconess Med Ctr, Dept Med, Div Hematol Oncol, Boston, MA 02215 USA

Dutcher, JP
论文数: 0 引用数: 0
h-index: 0
机构: Beth Israel Deaconess Med Ctr, Dept Med, Div Hematol Oncol, Boston, MA 02215 USA

Hudes, GR
论文数: 0 引用数: 0
h-index: 0
机构: Beth Israel Deaconess Med Ctr, Dept Med, Div Hematol Oncol, Boston, MA 02215 USA

Park, Y
论文数: 0 引用数: 0
h-index: 0
机构: Beth Israel Deaconess Med Ctr, Dept Med, Div Hematol Oncol, Boston, MA 02215 USA

Lion, SH
论文数: 0 引用数: 0
h-index: 0
机构: Beth Israel Deaconess Med Ctr, Dept Med, Div Hematol Oncol, Boston, MA 02215 USA

论文数: 引用数:
h-index:
机构:

Boni, JP
论文数: 0 引用数: 0
h-index: 0
机构: Beth Israel Deaconess Med Ctr, Dept Med, Div Hematol Oncol, Boston, MA 02215 USA

Dukart, G
论文数: 0 引用数: 0
h-index: 0
机构: Beth Israel Deaconess Med Ctr, Dept Med, Div Hematol Oncol, Boston, MA 02215 USA

Sherman, ML
论文数: 0 引用数: 0
h-index: 0
机构: Beth Israel Deaconess Med Ctr, Dept Med, Div Hematol Oncol, Boston, MA 02215 USA
[2]
Rapamycin synergizes with the epidermal growth factor receptor inhibitor erlotinib in non-small-cell lung, pancreatic, colon, and breast tumors
[J].
Buck, Elizabeth
;
Eyzaguirre, Alexandra
;
Brown, Eric
;
Petti, Filippo
;
McCormack, Siobhan
;
Haley, John D.
;
Iwata, Kenneth K.
;
Gibson, Neil W.
;
Griffin, Graeme
.
MOLECULAR CANCER THERAPEUTICS,
2006, 5 (11)
:2676-2684

Buck, Elizabeth
论文数: 0 引用数: 0
h-index: 0
机构: OSI Pharmaceut, Translat Res, Farmingdale, NY 11787 USA

Eyzaguirre, Alexandra
论文数: 0 引用数: 0
h-index: 0
机构: OSI Pharmaceut, Translat Res, Farmingdale, NY 11787 USA

Brown, Eric
论文数: 0 引用数: 0
h-index: 0
机构: OSI Pharmaceut, Translat Res, Farmingdale, NY 11787 USA

Petti, Filippo
论文数: 0 引用数: 0
h-index: 0
机构: OSI Pharmaceut, Translat Res, Farmingdale, NY 11787 USA

McCormack, Siobhan
论文数: 0 引用数: 0
h-index: 0
机构: OSI Pharmaceut, Translat Res, Farmingdale, NY 11787 USA

Haley, John D.
论文数: 0 引用数: 0
h-index: 0
机构: OSI Pharmaceut, Translat Res, Farmingdale, NY 11787 USA

Iwata, Kenneth K.
论文数: 0 引用数: 0
h-index: 0
机构: OSI Pharmaceut, Translat Res, Farmingdale, NY 11787 USA

Gibson, Neil W.
论文数: 0 引用数: 0
h-index: 0
机构: OSI Pharmaceut, Translat Res, Farmingdale, NY 11787 USA

Griffin, Graeme
论文数: 0 引用数: 0
h-index: 0
机构: OSI Pharmaceut, Translat Res, Farmingdale, NY 11787 USA
[3]
Phase II study of temsirolimus (CCI-779), a novel inhibitor of mTOR, in heavily pretreated patients with locally advanced or metastatic breast cancer
[J].
Chan, S
;
Scheulen, ME
;
Johnston, S
;
Mross, K
;
Cardoso, F
;
Dittrich, C
;
Eiermann, W
;
Hess, D
;
Morant, R
;
Semiglazov, V
;
Borner, M
;
Salzberg, M
;
Ostapenko, V
;
Illiger, HJ
;
Behringer, D
;
Bardy-Bouxin, N
;
Boni, J
;
Kong, S
;
Cincotta, M
;
Moore, L
.
JOURNAL OF CLINICAL ONCOLOGY,
2005, 23 (23)
:5314-5322

Chan, S
论文数: 0 引用数: 0
h-index: 0
机构: City Hosp Nottingham, Dept Clin Oncol, Nottingham N65 1PB, England

Scheulen, ME
论文数: 0 引用数: 0
h-index: 0
机构: City Hosp Nottingham, Dept Clin Oncol, Nottingham N65 1PB, England

Johnston, S
论文数: 0 引用数: 0
h-index: 0
机构: City Hosp Nottingham, Dept Clin Oncol, Nottingham N65 1PB, England

Mross, K
论文数: 0 引用数: 0
h-index: 0
机构: City Hosp Nottingham, Dept Clin Oncol, Nottingham N65 1PB, England

Cardoso, F
论文数: 0 引用数: 0
h-index: 0
机构: City Hosp Nottingham, Dept Clin Oncol, Nottingham N65 1PB, England

Dittrich, C
论文数: 0 引用数: 0
h-index: 0
机构: City Hosp Nottingham, Dept Clin Oncol, Nottingham N65 1PB, England

Eiermann, W
论文数: 0 引用数: 0
h-index: 0
机构: City Hosp Nottingham, Dept Clin Oncol, Nottingham N65 1PB, England

Hess, D
论文数: 0 引用数: 0
h-index: 0
机构: City Hosp Nottingham, Dept Clin Oncol, Nottingham N65 1PB, England

Morant, R
论文数: 0 引用数: 0
h-index: 0
机构: City Hosp Nottingham, Dept Clin Oncol, Nottingham N65 1PB, England

Semiglazov, V
论文数: 0 引用数: 0
h-index: 0
机构: City Hosp Nottingham, Dept Clin Oncol, Nottingham N65 1PB, England

Borner, M
论文数: 0 引用数: 0
h-index: 0
机构: City Hosp Nottingham, Dept Clin Oncol, Nottingham N65 1PB, England

Salzberg, M
论文数: 0 引用数: 0
h-index: 0
机构: City Hosp Nottingham, Dept Clin Oncol, Nottingham N65 1PB, England

Ostapenko, V
论文数: 0 引用数: 0
h-index: 0
机构: City Hosp Nottingham, Dept Clin Oncol, Nottingham N65 1PB, England

Illiger, HJ
论文数: 0 引用数: 0
h-index: 0
机构: City Hosp Nottingham, Dept Clin Oncol, Nottingham N65 1PB, England

Behringer, D
论文数: 0 引用数: 0
h-index: 0
机构: City Hosp Nottingham, Dept Clin Oncol, Nottingham N65 1PB, England

Bardy-Bouxin, N
论文数: 0 引用数: 0
h-index: 0
机构: City Hosp Nottingham, Dept Clin Oncol, Nottingham N65 1PB, England

Boni, J
论文数: 0 引用数: 0
h-index: 0
机构: City Hosp Nottingham, Dept Clin Oncol, Nottingham N65 1PB, England

Kong, S
论文数: 0 引用数: 0
h-index: 0
机构: City Hosp Nottingham, Dept Clin Oncol, Nottingham N65 1PB, England

Cincotta, M
论文数: 0 引用数: 0
h-index: 0
机构: City Hosp Nottingham, Dept Clin Oncol, Nottingham N65 1PB, England

Moore, L
论文数: 0 引用数: 0
h-index: 0
机构: City Hosp Nottingham, Dept Clin Oncol, Nottingham N65 1PB, England
[4]
Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: A north central cancer treatment group study
[J].
Galanis, E
;
Buckner, JC
;
Maurer, MJ
;
Kreisberg, JL
;
Ballman, K
;
Boni, J
;
Peralba, JM
;
Jenkins, RB
;
Dakhil, SR
;
Morton, RF
;
Jaeckle, KA
;
Scheithauer, BW
;
Dancey, J
;
Hidalgo, M
;
Walsh, DJ
.
JOURNAL OF CLINICAL ONCOLOGY,
2005, 23 (23)
:5294-5304

Galanis, E
论文数: 0 引用数: 0
h-index: 0
机构: Mayo Clin, Coll Med, N Cent Canc Treatment Grp, Rochester, MN USA

Buckner, JC
论文数: 0 引用数: 0
h-index: 0
机构: Mayo Clin, Coll Med, N Cent Canc Treatment Grp, Rochester, MN USA

Maurer, MJ
论文数: 0 引用数: 0
h-index: 0
机构: Mayo Clin, Coll Med, N Cent Canc Treatment Grp, Rochester, MN USA

Kreisberg, JL
论文数: 0 引用数: 0
h-index: 0
机构: Mayo Clin, Coll Med, N Cent Canc Treatment Grp, Rochester, MN USA

Ballman, K
论文数: 0 引用数: 0
h-index: 0
机构: Mayo Clin, Coll Med, N Cent Canc Treatment Grp, Rochester, MN USA

Boni, J
论文数: 0 引用数: 0
h-index: 0
机构: Mayo Clin, Coll Med, N Cent Canc Treatment Grp, Rochester, MN USA

Peralba, JM
论文数: 0 引用数: 0
h-index: 0
机构: Mayo Clin, Coll Med, N Cent Canc Treatment Grp, Rochester, MN USA

Jenkins, RB
论文数: 0 引用数: 0
h-index: 0
机构: Mayo Clin, Coll Med, N Cent Canc Treatment Grp, Rochester, MN USA

Dakhil, SR
论文数: 0 引用数: 0
h-index: 0
机构: Mayo Clin, Coll Med, N Cent Canc Treatment Grp, Rochester, MN USA

Morton, RF
论文数: 0 引用数: 0
h-index: 0
机构: Mayo Clin, Coll Med, N Cent Canc Treatment Grp, Rochester, MN USA

Jaeckle, KA
论文数: 0 引用数: 0
h-index: 0
机构: Mayo Clin, Coll Med, N Cent Canc Treatment Grp, Rochester, MN USA

Scheithauer, BW
论文数: 0 引用数: 0
h-index: 0
机构: Mayo Clin, Coll Med, N Cent Canc Treatment Grp, Rochester, MN USA

Dancey, J
论文数: 0 引用数: 0
h-index: 0
机构: Mayo Clin, Coll Med, N Cent Canc Treatment Grp, Rochester, MN USA

Hidalgo, M
论文数: 0 引用数: 0
h-index: 0
机构: Mayo Clin, Coll Med, N Cent Canc Treatment Grp, Rochester, MN USA

Walsh, DJ
论文数: 0 引用数: 0
h-index: 0
机构: Mayo Clin, Coll Med, N Cent Canc Treatment Grp, Rochester, MN USA
[5]
Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor
[J].
Guba, M
;
von Breitenbuch, P
;
Steinbauer, M
;
Koehl, G
;
Flegel, S
;
Hornung, M
;
Bruns, CJ
;
Zuelke, C
;
Farkas, S
;
Anthuber, M
;
Jauch, KW
;
Geissler, EK
.
NATURE MEDICINE,
2002, 8 (02)
:128-135

Guba, M
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Regensburg, Dept Surg, D-8400 Regensburg, Germany Univ Regensburg, Dept Surg, D-8400 Regensburg, Germany

von Breitenbuch, P
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Regensburg, Dept Surg, D-8400 Regensburg, Germany Univ Regensburg, Dept Surg, D-8400 Regensburg, Germany

Steinbauer, M
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Regensburg, Dept Surg, D-8400 Regensburg, Germany Univ Regensburg, Dept Surg, D-8400 Regensburg, Germany

Koehl, G
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Regensburg, Dept Surg, D-8400 Regensburg, Germany Univ Regensburg, Dept Surg, D-8400 Regensburg, Germany

Flegel, S
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Regensburg, Dept Surg, D-8400 Regensburg, Germany Univ Regensburg, Dept Surg, D-8400 Regensburg, Germany

论文数: 引用数:
h-index:
机构:

Bruns, CJ
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Regensburg, Dept Surg, D-8400 Regensburg, Germany Univ Regensburg, Dept Surg, D-8400 Regensburg, Germany

Zuelke, C
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Regensburg, Dept Surg, D-8400 Regensburg, Germany Univ Regensburg, Dept Surg, D-8400 Regensburg, Germany

Farkas, S
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Regensburg, Dept Surg, D-8400 Regensburg, Germany Univ Regensburg, Dept Surg, D-8400 Regensburg, Germany

Anthuber, M
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Regensburg, Dept Surg, D-8400 Regensburg, Germany Univ Regensburg, Dept Surg, D-8400 Regensburg, Germany

Jauch, KW
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Regensburg, Dept Surg, D-8400 Regensburg, Germany Univ Regensburg, Dept Surg, D-8400 Regensburg, Germany

Geissler, EK
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Regensburg, Dept Surg, D-8400 Regensburg, Germany Univ Regensburg, Dept Surg, D-8400 Regensburg, Germany
[6]
Blocking on the CXCR4/mTOR signalling pathway induces the anti-metastatic properties and autophagic cell death in peritoneal disseminated gastric cancer cells
[J].
Hashimoto, Isaya
;
Koizumi, Keiichi
;
Tatematsu, Mikiko
;
Minami, Takayuki
;
Cho, Seiji
;
Takeno, Nobuhiro
;
Nakashima, Akitoshi
;
Sakurai, Hiroaki
;
Saito, Shigeru
;
Tsukada, Kazuhiro
;
Saiki, Izuo
.
EUROPEAN JOURNAL OF CANCER,
2008, 44 (07)
:1022-1029

Hashimoto, Isaya
论文数: 0 引用数: 0
h-index: 0
机构:
Toyama Univ, Inst Nat Med, Div Pathogen Biochem, Toyama 930, Japan
Toyama Univ, Fac Med, Dept Surg 2, Toyama 930, Japan Toyama Univ, Inst Nat Med, Div Pathogen Biochem, Toyama 930, Japan

论文数: 引用数:
h-index:
机构:

Tatematsu, Mikiko
论文数: 0 引用数: 0
h-index: 0
机构:
Toyama Univ, Dept Obstet & Gynecol, Toyama 930, Japan Toyama Univ, Inst Nat Med, Div Pathogen Biochem, Toyama 930, Japan

Minami, Takayuki
论文数: 0 引用数: 0
h-index: 0
机构:
Toyama Univ, Inst Nat Med, Div Pathogen Biochem, Toyama 930, Japan Toyama Univ, Inst Nat Med, Div Pathogen Biochem, Toyama 930, Japan

Cho, Seiji
论文数: 0 引用数: 0
h-index: 0
机构:
Toyama Univ, Inst Nat Med, Div Pathogen Biochem, Toyama 930, Japan
Toyama Univ, Fac Med, Dept Surg 2, Toyama 930, Japan Toyama Univ, Inst Nat Med, Div Pathogen Biochem, Toyama 930, Japan

Takeno, Nobuhiro
论文数: 0 引用数: 0
h-index: 0
机构:
Toyama Univ, Inst Nat Med, Div Pathogen Biochem, Toyama 930, Japan Toyama Univ, Inst Nat Med, Div Pathogen Biochem, Toyama 930, Japan

Nakashima, Akitoshi
论文数: 0 引用数: 0
h-index: 0
机构:
Toyama Univ, Dept Obstet & Gynecol, Toyama 930, Japan Toyama Univ, Inst Nat Med, Div Pathogen Biochem, Toyama 930, Japan

论文数: 引用数:
h-index:
机构:

论文数: 引用数:
h-index:
机构:

Tsukada, Kazuhiro
论文数: 0 引用数: 0
h-index: 0
机构:
Toyama Univ, Fac Med, Dept Surg 2, Toyama 930, Japan Toyama Univ, Inst Nat Med, Div Pathogen Biochem, Toyama 930, Japan

Saiki, Izuo
论文数: 0 引用数: 0
h-index: 0
机构:
Toyama Univ, Inst Nat Med, Div Pathogen Biochem, Toyama 930, Japan
Toyama Univ, 21st Century COE Program, Toyama 930, Japan Toyama Univ, Inst Nat Med, Div Pathogen Biochem, Toyama 930, Japan
[7]
A multicenter study on oncologic outcome of laparoscopic gastrectomy for early cancer in Japan
[J].
Kitano, Seigo
;
Shiraishi, Norio
;
Uyama, Ichiro
;
Sugihara, Kenichi
;
Tanigawa, Nobuhiko
.
ANNALS OF SURGERY,
2007, 245 (01)
:68-72

Kitano, Seigo
论文数: 0 引用数: 0
h-index: 0
机构: Oita Univ, Fac Med, Dept Surg 1, Oita 8795593, Japan

Shiraishi, Norio
论文数: 0 引用数: 0
h-index: 0
机构: Oita Univ, Fac Med, Dept Surg 1, Oita 8795593, Japan

论文数: 引用数:
h-index:
机构:

Sugihara, Kenichi
论文数: 0 引用数: 0
h-index: 0
机构: Oita Univ, Fac Med, Dept Surg 1, Oita 8795593, Japan

Tanigawa, Nobuhiko
论文数: 0 引用数: 0
h-index: 0
机构: Oita Univ, Fac Med, Dept Surg 1, Oita 8795593, Japan
[8]
Rapamycin, a specific inhibitor of the mammalian target of rapamycin, suppresses lymphangiogenesis and lymphatic metastasis
[J].
Kobayashi, Soichi
;
Kishimoto, Takashi
;
Kamata, Shigeyuki
;
Otsuka, Masayuki
;
Miyazaki, Masaru
;
Ishikura, Hiroshi
.
CANCER SCIENCE,
2007, 98 (05)
:726-733

Kobayashi, Soichi
论文数: 0 引用数: 0
h-index: 0
机构: Chiba Univ, Grad Sch Med, Dept Mol Pathol, Chiba 2608670, Japan

Kishimoto, Takashi
论文数: 0 引用数: 0
h-index: 0
机构: Chiba Univ, Grad Sch Med, Dept Mol Pathol, Chiba 2608670, Japan

Kamata, Shigeyuki
论文数: 0 引用数: 0
h-index: 0
机构: Chiba Univ, Grad Sch Med, Dept Mol Pathol, Chiba 2608670, Japan

Otsuka, Masayuki
论文数: 0 引用数: 0
h-index: 0
机构: Chiba Univ, Grad Sch Med, Dept Mol Pathol, Chiba 2608670, Japan

论文数: 引用数:
h-index:
机构:

Ishikura, Hiroshi
论文数: 0 引用数: 0
h-index: 0
机构: Chiba Univ, Grad Sch Med, Dept Mol Pathol, Chiba 2608670, Japan
[9]
Mammalian target of rapamycin is activated in human gastric cancer and serves as a target for therapy in an experimental model
[J].
Lang, Sven A.
;
Gaumann, Andreas
;
Koehl, Gudrun E.
;
Seidel, Ulrike
;
Bataille, Franke
;
Klein, Dagmar
;
Ellis, Lee M.
;
Bolder, Ulrich
;
Hofstaedter, Ferdinand
;
Schlitt, Hans-Juergen
;
Geissler, Edward K.
;
Stoeltzing, Oliver
.
INTERNATIONAL JOURNAL OF CANCER,
2007, 120 (08)
:1803-1810

Lang, Sven A.
论文数: 0 引用数: 0
h-index: 0
机构: Univ Regensburg, Dept Surg, Med Ctr, D-93053 Regensburg, Germany

Gaumann, Andreas
论文数: 0 引用数: 0
h-index: 0
机构: Univ Regensburg, Dept Surg, Med Ctr, D-93053 Regensburg, Germany

Koehl, Gudrun E.
论文数: 0 引用数: 0
h-index: 0
机构: Univ Regensburg, Dept Surg, Med Ctr, D-93053 Regensburg, Germany

Seidel, Ulrike
论文数: 0 引用数: 0
h-index: 0
机构: Univ Regensburg, Dept Surg, Med Ctr, D-93053 Regensburg, Germany

Bataille, Franke
论文数: 0 引用数: 0
h-index: 0
机构: Univ Regensburg, Dept Surg, Med Ctr, D-93053 Regensburg, Germany

Klein, Dagmar
论文数: 0 引用数: 0
h-index: 0
机构: Univ Regensburg, Dept Surg, Med Ctr, D-93053 Regensburg, Germany

Ellis, Lee M.
论文数: 0 引用数: 0
h-index: 0
机构: Univ Regensburg, Dept Surg, Med Ctr, D-93053 Regensburg, Germany

Bolder, Ulrich
论文数: 0 引用数: 0
h-index: 0
机构: Univ Regensburg, Dept Surg, Med Ctr, D-93053 Regensburg, Germany

Hofstaedter, Ferdinand
论文数: 0 引用数: 0
h-index: 0
机构: Univ Regensburg, Dept Surg, Med Ctr, D-93053 Regensburg, Germany

Schlitt, Hans-Juergen
论文数: 0 引用数: 0
h-index: 0
机构: Univ Regensburg, Dept Surg, Med Ctr, D-93053 Regensburg, Germany

Geissler, Edward K.
论文数: 0 引用数: 0
h-index: 0
机构: Univ Regensburg, Dept Surg, Med Ctr, D-93053 Regensburg, Germany

Stoeltzing, Oliver
论文数: 0 引用数: 0
h-index: 0
机构: Univ Regensburg, Dept Surg, Med Ctr, D-93053 Regensburg, Germany
[10]
mTOR and P70S6 kinase expression in primary liver neoplasms
[J].
Sahin, F
;
Kannangai, R
;
Adegbola, O
;
Wang, JZ
;
Su, G
;
Torbenson, M
.
CLINICAL CANCER RESEARCH,
2004, 10 (24)
:8421-8425

Sahin, F
论文数: 0 引用数: 0
h-index: 0
机构: Johns Hopkins Univ Hosp, Dept Pathol, Baltimore, MD 21287 USA

Kannangai, R
论文数: 0 引用数: 0
h-index: 0
机构: Johns Hopkins Univ Hosp, Dept Pathol, Baltimore, MD 21287 USA

Adegbola, O
论文数: 0 引用数: 0
h-index: 0
机构: Johns Hopkins Univ Hosp, Dept Pathol, Baltimore, MD 21287 USA

Wang, JZ
论文数: 0 引用数: 0
h-index: 0
机构: Johns Hopkins Univ Hosp, Dept Pathol, Baltimore, MD 21287 USA

Su, G
论文数: 0 引用数: 0
h-index: 0
机构: Johns Hopkins Univ Hosp, Dept Pathol, Baltimore, MD 21287 USA

Torbenson, M
论文数: 0 引用数: 0
h-index: 0
机构: Johns Hopkins Univ Hosp, Dept Pathol, Baltimore, MD 21287 USA